Exchange: NASDAQ·Updated 11:33 AM EDT
News
all
press releases
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates
Kardigan, Inc. (Nasdaq: KARD) (Kardigan or the Company), a clinical-stage precision therapeutics company developing medicines that target the root causes of cardiovascular diseases with no approved treatments, today reported financial results from the second quarter ended June 30, 2026, and...
Business Wire
Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Kardigan, Inc. (Nasdaq: KARD) (Kardigan), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist, today announced the closing of its initial public offering of an aggregate 28,750,000...
Business Wire
Kardigan Announces Pricing of Upsized Initial Public Offering
Kardigan, Inc. (Nasdaq: KARD) (Kardigan), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist, today announced the pricing of its initial public offering of 25,000,000 shares of common...
Business Wire

Advertisement|Remove ads.